Show simple item record

dc.contributor.authorUsman, S
dc.contributor.authorJamal, A
dc.contributor.authorTeh, M-T
dc.contributor.authorWaseem, A
dc.date.accessioned2021-02-08T12:36:59Z
dc.date.available2021-02-08T12:36:59Z
dc.date.issued2020-01-25
dc.identifier.citationUsman S, Jamal A, Teh M-T and Waseem A (2021) Major Molecular Signaling Pathways in Oral Cancer Associated With Therapeutic Resistance. Front. Oral. Health 1:603160. doi: 10.3389/froh.2020.603160en_US
dc.identifier.issn2673-4842
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/70164
dc.description.abstractOral cancer is a sub-category of head and neck cancers that primarily initiates in the oral cavity. The primary treatment option for oral cancer remains surgery but it is associated with massive disfigurement, inability to carry out normal oral functions, psycho-social stress and exhaustive rehabilitation. Other treatment options such as chemotherapy and radiotherapy have their own limitations in terms of toxicity, intolerance and therapeutic resistance. Immunological treatments to enhance the body's ability to recognize cancer tissue as a foreign entity are also being used but they are new and underdeveloped. Although substantial progress has been made in the treatment of oral cancer, its complex heterogeneous nature still needs to be explored, to elucidate the molecular basis for developing resistance to therapeutic agents and how to overcome it, with the aim of improving the chances of patients' survival and their quality of life. This review provides an overview of up-to-date information on the complex role of the major molecules and associated signaling, epigenetic changes, DNA damage repair systems, cancer stem cells and micro RNAs in the development of therapeutic resistance and treatment failure in oral cancer. We have also summarized the current strategies being developed to overcome these therapeutic challenges. This review will help not only researchers but also oral oncologists in the management of the disease and in developing new therapeutic modalities.en_US
dc.format.extent603160
dc.publisherFrontiers Mediaen_US
dc.relation.ispartofFrontiers in Oral Health
dc.rightsThis is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY)
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.titleMajor Molecular Signaling Pathways in Oral Cancer Associated With Therapeutic Resistanceen_US
dc.typeArticleen_US
dc.rights.holder© 2021 Usman, Jamal, Teh and Waseem
dc.identifier.doi10.3389/froh.2020.603160
pubs.notesNot knownen_US
pubs.publisher-urlhttps://www.frontiersin.org/articles/10.3389/froh.2020.603160/full
pubs.volume1en_US
rioxxterms.funderDefault funderen_US
rioxxterms.identifier.projectDefault projecten_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY)
Except where otherwise noted, this item's license is described as This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY)